Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
Currently, there are no commercially available live‐attenuated vaccines against chikungunya virus (CHIKV). Here, CHIKVs with mutations in non‐structural proteins (nsPs) were investigated for their suitability as attenuated CHIKV vaccines. R532H mutation in nsP1 caused reduced infectivity in mouse ta...
Päätekijät: | Chan, Y, Teo, T, Utt, A, Tan, JJ, Amrun, SN, Abu Bakar, F, Yee, W, Becht, E, Lee, CY, Lee, B, Rajarethinam, R, Newell, E, Merits, A, Carissimo, G, Lum, F, Ng, LF |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Springer
2019
|
Samankaltaisia teoksia
-
VCP/p97 is a proviral host factor for replication of chikungunya virus and other alphaviruses
Tekijä: Carissimo, Guillaume, et al.
Julkaistu: (2020) -
Design and use of Chikungunya virus replication templates utilizing mammalian and mosquito RNA polymerase I mediated transcription
Tekijä: Utt, A, et al.
Julkaistu: (2019) -
Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase
Tekijä: Law, Yee-Song, et al.
Julkaistu: (2020) -
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
Tekijä: Lum, Fok-Moon, et al.
Julkaistu: (2024) -
Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
Tekijä: Oo, Adrian, et al.
Julkaistu: (2018)